Danaparoid in the prevention of ischemic stroke in paroxysmal nocturnal hemoglobinuria.
Zyss
J
J
Cerebrovascular Unit, Hôpital P. Wertheimer, Lyon, France.
Cakmak
S
S
Derex
L
L
Michallet
M
M
Nighoghossian
N
N
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications / Q000188:drug therapy*; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D020762:Infarction, Posterior Cerebral Artery / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D016896:Treatment Outcome
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006497:Heparan Sulfate; C035838:danaparoid